<DOC>
	<DOCNO>NCT00158912</DOCNO>
	<brief_summary>The purpose VAST determine whether Rate Smoothing feature Guidant ’ PRIZM/VITALITY-family ICDs effect incidence ventricular tachyarrhythmias .</brief_summary>
	<brief_title>VAST - Ventricular Arrhythmia Suppression Trial</brief_title>
	<detailed_description />
	<mesh_term>Tachycardia</mesh_term>
	<criteria>Patients receive commercially available Guidant PRIZM , PRIZM 2 , VITALITY AVT ICD Patients sign date Patient Informed Consent prior study enrollment Patients remain clinical care physician implant center Patients chronic atrial fibrillation . Paroxysms AF exclusion criterion , patient must normal sinus rhythm time randomization . If history AF unknown uncertain , patient recently cardioverted , must least 23 hour normal sinus rhythm within 24 hour period precede randomization Patients previously ICD Patients current indication cardiac resynchronization therapy defibrillation ( CRTD ) Patients whose life expectancy le 12 month due medical condition Patients expect receive heart transplant duration study Patients likely receive tricuspid valve prosthesis Patients currently enrol another investigational study active medical therapy . Each instance bring Guidant ’ Clinical Application Research Studies ( CARS ) group determine eligibility Patients young 18 year age Patients mentally incompetent give Patient Informed Consent participate study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2006</verification_date>
</DOC>